Fosamprenavir Expanded Access

NCT00240552 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: fosamprenavir
DRUG: Telzir®

Sponsor

ViiV Healthcare

Collaborators

[object Object]